Financhill
Buy
53

CRTO Quote, Financials, Valuation and Earnings

Last price:
$20.11
Seasonality move :
4.47%
Day range:
$19.84 - $20.37
52-week range:
$19.00 - $47.27
Dividend yield:
0%
P/E ratio:
6.74x
P/S ratio:
0.57x
P/B ratio:
0.93x
Volume:
141.1K
Avg. volume:
521.4K
1-year change:
-51.07%
Market cap:
$1.1B
Revenue:
$1.9B
EPS (TTM):
$2.98

Earnings Data

Next earnings date for CRTO
Feb 04
2026
Most recent earnings per share
$0.70
Missed by $0.23
(Oct 29/2025)
Consensus Estimate
$0.93
(Oct 29/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CRTO Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/04/2026 Q4 $328.9M -- -- $1.41 --
10/29/2025 Q3 $281.6M $467.6M $0.70 $0.93 -$0.23
07/30/2025 Q2 $274.7M $488.8M $0.39 $0.71 -$0.32
05/02/2025 Q1 $260.3M $451.8M $0.66 $0.77 -$0.11
02/05/2025 Q4 $327.8M $549.1M $1.22 $1.35 -$0.12
10/30/2024 Q3 $267M $460.2M $0.11 $0.83 -$0.72
08/01/2024 Q2 $263.6M $471.3M $0.46 $0.77 -$0.31
05/02/2024 Q1 $244.7M $450.1M $0.12 $0.54 -$0.42
02/07/2024 Q4 $300.1M $566.3M $1.02 $1.24 -$0.22
11/02/2023 Q3 -- -- $0.12 $0.60 -$0.48
08/02/2023 Q2 -- -- -$0.05 $0.44 -$0.49
05/03/2023 Q1 -- -- -$0.21 $0.24 -$0.45
02/08/2023 Q4 -- -- $0.25 $0.96 -$0.71
10/28/2022 Q3 -- -- $0.10 $0.48 -$0.38
08/03/2022 Q2 -- -- -$0.56 $0.43 -$0.99
05/04/2022 Q1 -- -- $0.32 $0.44 -$0.12
02/09/2022 Q4 -- -- $1.15 $1.08 $0.07
11/03/2021 Q3 -- -- $0.37 $0.36 $0.01
08/04/2021 Q2 -- -- $0.23 $0.47 -$0.24
05/05/2021 Q1 -- -- $0.35 $0.51 -$0.16
02/10/2021 Q4 -- -- $0.73 $0.76 -$0.03
10/28/2020 Q3 -- -- $0.09 $0.20 -$0.11
07/29/2020 Q2 -- -- $0.09 -$0.02 $0.11
04/29/2020 Q1 -- -- $0.25 $0.44 -$0.19
02/11/2020 Q4 -- -- $0.65 $0.91 -$0.26
10/30/2019 Q3 -- -- $0.28 $0.50 -$0.22
07/31/2019 Q2 -- -- $0.16 $0.41 -$0.25
04/30/2019 Q1 -- -- $0.29 $0.43 -$0.14
02/13/2019 Q4 -- -- $0.57 -- --
10/31/2018 Q3 -- -- $0.25 -- --
08/01/2018 Q2 -- -- $0.16 -- --
05/02/2018 Q1 -- -- $0.29 -- --
02/14/2018 Q4 -- -- $0.78 -- --
11/01/2017 Q3 -- -- $0.29 -- --
08/02/2017 Q2 -- -- $0.09 -- --
05/03/2017 Q1 -- -- $0.18 -- --
02/22/2017 Q4 -- -- $0.60 -- --
11/02/2016 Q3 -- -- $0.21 -- --
08/03/2016 Q2 -- -- $0.19 -- --
05/04/2016 Q1 -- -- $0.26 -- --
02/10/2016 Q4 -- -- $0.53 -- --

Criteo SA Earnings Questions

  • How Much did Criteo SA Generate in Revenue Last Quarter?

    Criteo SA reported $467.6M worth of top line sales in its most recent quarter.

  • Did Criteo SA Beat Earnings Last Quarter?

    Criteo SA announced earnings per share of $0.70 which represents a miss of analyst forecast a $0.93 per share.

  • Is Criteo SA Profitable?

    Criteo SA reported $255.3M that represents $4.75 per share over the last quarter.

  • What is the Analyst Consensus for Criteo SA EPS Next Year?

    Criteo SA's earnings are forecast to grow from $1.90 per share to $4.18 per share next year representing an increase of 145.54%.

  • When is Criteo SA's Earnings Date?

    Criteo SA's next earnings date is February 4, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock